Ocumension Therapeutics ^Investors

Ocumension Therapeutics is a China-based pharmaceutical platform company focused on developing and commercializing ophthalmic therapies. Their goal is to provide a comprehensive solution to address unmet medical needs in the field of ophthalmology in China. They have built a platform that integrates specialized capabilities in research and development, manufacturing, and commercialization of ophthalmic drugs. Ocumension Therapeutics aims to achieve leadership in the Chinese ophthalmology market and has recently announced an agreement with Alcon Inc. to acquire or secure commercialization rights for a portfolio of dry eye treatments and procedural drops.